前收市價 | 8.21 |
開市 | 8.20 |
買盤 | 7.88 x 100 |
賣出價 | 8.03 x 200 |
今日波幅 | 7.91 - 8.26 |
52 週波幅 | 4.00 - 40.60 |
成交量 | |
平均成交量 | 666,025 |
市值 | 185.395M |
Beta 值 (5 年,每月) | 0.19 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -4.00 |
業績公佈日 | 2024年5月13日 - 2024年5月17日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 39.91 |
13D FILINGS These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities.
The broader medical therapeutic sector is already volatile so it stands to reason in some sense to consider under-$10 biotech stocks. Imagine you acquired shares of a popular, richly priced enterprise, only for the underlying security to suffer due to a poor clinical result. And poor results can happen to anybody, big or small. Indeed, the prospect of being on the wrong end of a giant killing adds significant risk to market participants. So, as a calculated approach, since you’re going to be tak
In this article, we will take a detailed look at Insiders are Piling into These 10 Healthcare Stocks in 2024. For a quick overview of such stocks, read our article Insiders are Piling into These 5 Healthcare Stocks in 2024. Healthcare investors were nervous when 2024 started, since election years usually don’t bode well for healthcare stocks. But […]